|
Mar 12
|
Orthofix Announces Appointment of Vickie Capps to Board of Directors
|
|
Mar 3
|
Orthofix to Participate in the 37th Annual Roth Conference
|
|
Feb 26
|
Orthofix Medical Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 26
|
Q4 2024 Orthofix Medical Inc Earnings Call
|
|
Feb 26
|
Orthofix Medical Inc (OFIX) Q4 2024 Earnings Call Highlights: Record Growth and Strategic Shifts
|
|
Feb 25
|
Orthofix (OFIX) Q4 Earnings Lag Estimates
|
|
Feb 25
|
Orthofix: Q4 Earnings Snapshot
|
|
Feb 25
|
Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance
|
|
Feb 22
|
With 55% ownership, Orthofix Medical Inc. (NASDAQ:OFIX) boasts of strong institutional backing
|
|
Sep 23
|
Orthofix Highlights New Products and Announces Presentation of Data Supporting the Adjunct Use of Bone Growth Therapy for Lumbar Spine Fusion at North American Spine Society Annual Meeting
|
|
Aug 30
|
Orthofix Medical Inc (NASDAQ:OFIX) A Bull Case Theory
|
|
Jun 24
|
Michael Finegan Named Chair of the Orthofix Board of Directors
|
|
Jun 24
|
Orthofix’s president of global orthopedics resigns
|
|
Jun 18
|
Aviva McPherron Joins Orthofix as President of Global Operations and Quality
|
|
May 13
|
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
|
|
May 9
|
Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
|
|
May 8
|
Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Orthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
|
|
May 8
|
Q1 2024 Orthofix Medical Inc Earnings Call
|
|
May 7
|
Orthofix Medical Inc. (OFIX) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Net Loss Widening
|